LTFU Study of Subjects Who Received GRNOPC1

Running, not enrolling

Conditions studied: Spinal Cord Injuries

In brief

This is a LTFU study for thoracic SCI subjects that were administered GRNOPC1 cells in the main study CP35A007.

Key facts

Study ID

NCT05919563

Run by

Lineage Cell Therapeutics, Inc.

People needed

5

Starts

2011-10-06

Expected to finish

2026-12-12

Last updated by the study team

2024-08-21

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who received administration of GRNOPC1 under clinical study protocol CP35A007.

You may not qualify if…

• There are no exclusion criteria for this LTFU study.

Where it is running

• Stanford University — Palo Alto, California, United States
• Shepherd Center — Atlanta, Georgia, United States
• Northwestern Medical Group — Evanston, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.